Notice ID: b3651fb54d4b451396a690f3c35983baPresolicitation
Lorrca Ektacytometry Instrument
Archived on August 20, 2023. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 9:00 AM UTC−04:00
- Posted
- August 13, 2023
- Notice type
- Presolicitation
- NAICS
- 334516: Analytical Laboratory Instrument Manufacturing
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NICHD
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- NICHD23313
- Notice ID
- b3651fb54d4b451396a690f3c35983ba
Description
INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION. The National Institutes of Health, National Institute of Child Health and Development (NICHD), in support of the work of the National Institute of Diabetes, Digestive, and Kidney Disease (NIDDK), intends to award a purchase order without providing for full and open competition (Including brand-name) to RR Mechatronics to procure a Lorrca Ektacytometry Instrument. NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 334516 with a Size Standard 1000. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Regulation (FAR) Circular (FAC) 2023-01 effective 12-30-2022. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($250,000) and FAR Subpart 12- Acquisition of Commercial Items. STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13 Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13 Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6 Competition Requirements. Place of Performance National Institutes of Health 9000 Rockville Pike Bethesda MD 20892 United States DESCRIPTION OF REQUIREMENT The NIDDK supports a wide range of medical research through grants to universities and other medical research institutions across the country. The Institute also supports government scientists who conduct basic, translational, and clinical research across a broad spectrum of research topics and serious, chronic diseases and conditions related to the Institute's mission. In addition, the NIDDK supports research training for students and scientists at various stages of their careers and a range of education and outreach programs to bring science-based information to patients and their families, health care professionals, and the public. The Lorrca is a unique instrument that combines Red Blood Cell (RBC) deformability as a function of osmolality, aggregometry or oxygen pressure; all temperature controlled. Furthermore, it is capable of fully automated measurement and calculation of various phenomena of RBCs by analysis of their rheological behavior. REQUIRED FEATURES AND SPECIFICATIONS 1 Each Lorrca Oxygenscan 100 Vials of 5ML Elon ISO 100 vials of 5mL Oxy ISO 500mL Osmo LOW (0M) 500mL Osmo HIGH (500M) 5L X-Clean Transportation On-Site Install TASK AREAS Task Area 1 Shipping: The Lorrca Ektacytometry Instrument will need to be delivered to: The National Institutes of Health, NIDDK, Bethesda, Maryland 20892. Task Area 2 Delivery Delivery shall be within (12) weeks (ARO) after receipt of order by the vendor. The Contractor shall contact end-user to schedule inside delivery. Task Area 4 Warranty The instrument is covered by a full (1) year warranty with technical support for initial set-up support, diagnostic technical support, advanced parts replacement, and onsite service. Task Area 5 Installation & Training The Contractor shall schedule a training for two (2) days and three (3) hours each meeting. The Installation and training will be performed via video conference to include installation, setup, and testing. A Quality Control Certificate will be issued after testing and training. CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND- NAME) DETERMINATION The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10 Market Research. Only one source is available: Per FAR 13.106-1(b)(1) the Contracting Officer has determined that RR Mechatronics is the only vendor that can provide the Lorrca Ektacytometry Instrument. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provided feedback to respondents with respect to any information submitted. Responses to this notice shall contain sufficient information to establish the interested parties bona-fide capabilities for fulfilling the requirement, unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Vendor/Contractors (UEI) the Unique Entity ID from SAM.gov is now the authoritative identifier for those doing business with the federal government. The DUNS Number is no longer valid for federal award identification, the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses to this notice (NICHD-23-313) shall be submitted electronically by 9:00 AM Eastern Standard Time, on August 19, 2023. Assessment of Capability The contractor will be evaluated on their capability to provide the product to the specifications as stated on the solicitation and shall be required to provide required service with certification from the OEM.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
NICHD23313- Pre-Solicitation
Formal solicitation typically follows within 30–60 days. (estimate)
- Pre-SolicitationCurrentAug 13, 2023
Lorrca Ektacytometry Instrument
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
The National Institutes of Health (NIH), National Institute of Child Health and Human Development (NICHD), intends to award a contract to BIO-RAD on a sole-source basis pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements, for the acquisition of QX700 E Droplet Digital PCR System, the Government intends to solicit and award a Purchase Order on a solesource basis because the Government's minimum technical requirements will be satisfied by BIO-RAD. DTM’s shared labs have ongoing experiments that require very precise assessment of sample quality and quantity. The QX700 E Droplet Digital PCR System delivers the power of absolute quantification for our labs — without the need for standard curves. With simple setup, intuitive analysis, and 7-color multiplexing, it makes digital PCR more accessible than ever. All-in-one, integrated instrument enabling walkaway operation. Intuitive software with a user-friendly interface for easy run setup and data analysis. Generates absolute quantification results with intuitive software. A compact system built for low throughput or ad hoc studies and shared research spaces. Supports from 16, 32, or up to 48 samples per run, ensuring flexibility for low-throughput laboratories. The QX700 E Droplet Digital PCR System* delivers the power of absolute quantification for our labs — without the need for standard curves. With simple setup, intuitive analysis, and 7-color multiplexing, it makes digital PCR more accessible than ever. All-in-one, integrated instrument enabling walkaway operation. Intuitive software with a user-friendly interface for easy run setup and data analysis. Generates absolute quantification results with intuitive software. A compact system built for low throughput or ad hoc studies and shared research spaces. Supports from 16, 32, or up to 48 samples per run, ensuring flexibility for low-throughput laboratories. BioRad Laboratories, Inc. is the original manufacturer and sole supplier of the QX700 E Droplet Digital PCR System. This piece of equipment utilizes Droplet Digital PCR for the absolute quantification of nucleic acids. This notice is not a request for competitive quotations. However, interested parties that believe they can meet the Government's requirements may submit a capability statement demonstrating their ability to provide the required supplies and meet all specified technical and operational requirements. The Government will consider all timely capability statements received and determine whether the acquisition should proceed as a sole-source procurement or be competed. The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source is capable of meeting the requirement. Capability statements shall be submitted electronically to davisroshonna@mail.nih.gov no later than 9:00 a.m. EDT on November 18, 2026. Please reference Notice No. 75N98027Q00057 in the subject line of the response. | - | Combined Synopsis | 11/18/2026 |
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith FAR Subpart 12.6, as supplemented with additional information included in thisnotice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00077. This solicitation is issued as a competitiveRequest for Quotation (RFQ) / combined synopsis/solicitation for commercial productsand commercial services using a Brand Name restriction in accordance with FAR 13.106-1(b)(1)(i). A Brand Name Justification is attached to this notice in accordance with FAR5.102(a)(6). This acquisition is conducted under the authority of FAR 12.603, StreamlinedSolicitation for Commercial Products or Commercial Services, in conjunction with FAR Part13 Simplified Acquisition Procedures, and is not expected to exceed the simplifiedacquisition threshold. The National Institutes of Health (NIH), Office of the Director, Officeof Acquisitions, seeks to award a Firm-Fixed-Price (FFP) Purchase Order to theresponsible offeror whose quotation represents the best value to the Government. (iii)The solicitation document and incorporated provisions and clauses are those in effectthrough Federal Acquisition Circular (FAC) number 2026-01 and effective date 03/13/2026. (iv)The associated NAICS code is 334516 (Analytical Laboratory InstrumentManufacturing), and the small business size standard is 1,000 employees. The ProductService Code (PSC) is 6640 (Laboratory Equipment and Supplies). [X]This requirement is set aside for Small Business concerns. | - | Combined Synopsis | 11/24/2026 |
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00072. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services restricted to the Brand Name specified herein in accordance with FAR 13.106-1(b)(1)(i). The Government intends to award a firm-fixed-price purchase order resulting from this solicitation using competition among the Original Equipment Manufacturer (OEM) and its authorized distributors. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, on behalf of the National Heart, Lung, and Blood Institute (NHLBI), seeks to award a firm-fixed-price purchase order to the responsible offeror whose proposal represents the best value to the Government. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv) The associated NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing), and the small business size standard is 1,000 employees. ¿ This requirement is unrestricted. (v) Description of Requirement: The National Heart, Lung, and Blood Institute (NHLBI), Laboratory of Advanced Microscopy and Biophotonics (LAMB), requires one (1) Brand Name Spectra-Physics (Newport Corporation / MKS Instruments) InSight® X3¿ Dual Ultrafast Laser System to integrate with an existing Thorlabs Veneto inverted multiphoton microscope for Fluorescence Lifetime Imaging Microscopy (FLIM) and Stimulated Raman Scattering (SRS) pump-probe experiments studying the effects of chemotherapeutic agents on cellular metabolism. | - | Combined Synopsis | 11/20/2026 |
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00064 PCA-NIA-11888. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a firm fixed-price award to the responsible offeror whose proposal represents the best value to the Government. | - | Combined Synopsis | 12/14/2026 |
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith FAR Subpart 12.6, as supplemented with additional information included in thisnotice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00061. This solicitation is issued as a competitivecombined synopsis/solicitation for commercial products or commercial services (BrandName or Equal in accordance with FAR 52.211-6). The Government intends to award acontract or purchase order resulting from this solicitation using full and open competition.This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitationfor Commercial Products or Commercial Services (and FAR Subpart 13.5, as applicable).The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeksto award a Firm-Fixed-Price (FFP) Purchase Order/Contract in U.S. Dollars (USD) to theresponsible offeror whose proposal represents the best value to the Government. (iii)The solicitation document and incorporated provisions and clauses are those in effectthrough Federal Acquisition Circular 2026-01 and effective date 03/13/2026. (iv)The associated NAICS code is 334516 (Analytical Laboratory InstrumentManufacturing), and the small business size standard is 1,000 employees. ¿This requirement is unrestricted. | - | Combined Synopsis | 11/18/2026 |
Additional Details
Solicitation Number
NICHD23313
Archive Date
Aug 20, 2023
Office Address
BETHESDA, MD, 20817